Equels Thomas K sold AIM
March 12, 2026 · Form 4 insider transaction
Equels Thomas K sold 25 shares of AIM ImmunoTech Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
25
Price
$0.00
Total value
N/A
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecuritySeries G Convertible Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Preferred shares are convertible into common stock at a rate of 1,000 shares of common stock per whole perferred share, effectively $1.00 per share of common stock.; None